Cardiac hypertrophy diminished the effects of isoproterenol on delayed rectifier potassium current in rat heart
Related Experiment Video
Updated: Aug 7, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
Tomohiko Sakatani1, Takeshi Shirayama, Taku Yamamoto
1Department of Cardiovascular Medicine, Kyoto Prefectural University of Medicine, Kyoto, Japan. sakatani@koto.kpu-m.ac.jp
Insights
In hypertrophic rat hearts, reduced potassium current (I(K)) prolongs action potential duration. Isoproterenol fails to stimulate I(K) due to increased phosphodiesterase activity, worsening heart dysfunction.
Area of Science:
- Cardiology
- Electrophysiology
- Molecular Cardiology
Background:
- Left ventricular hypertrophy (LVH) alters cardiac electrophysiology.
- Sympathetic nerve activity influences ion channel function in the heart.
Purpose of the Study:
- To investigate the relationship between sympathetic stimulation and potassium current (I(K)) in a rat model of cardiac hypertrophy.
- To elucidate the mechanisms behind altered action potential duration (APD) in hypertrophic hearts.
Main Methods:
- Induction of LVH via suprarenal aortic constriction in rats.
- Whole-cell patch clamp technique to measure ion currents (I(K), I(Ca)) and APD.
- Pharmacological stimulation with isoproterenol, forskolin, and IBMX.
Main Results:
- Hypertrophic hearts showed a 28.2% decrease in I(K), leading to prolonged APD(90).
- Isoproterenol failed to stimulate I(K) in hypertrophic hearts, unlike in sham controls.
- Isoproterenol increased L-type calcium current (I(Ca)) similarly in both groups, further prolonging APD in hypertrophic hearts.
- Forskolin did not enhance I(K) in hypertrophy, but IBMX did, suggesting a role for phosphodiesterase.
Conclusions:
- Enhanced phosphodiesterase activity in hypertrophic hearts impairs isoproterenol-mediated I(K) stimulation.
- This impairment contributes to excessive action potential duration prolongation and cardiac dysfunction in hypertrophy.
Abstract:
We investigated the association between sympathetic nerve activity and delayed rectifier potassium current (I(K)) in hypertrophic rat hearts. Left ventricular hypertrophy was induced by a 50% constriction of suprarenal abdominal aorta for 6 weeks. The effects of isoproterenol on action potential duration (APD), I(K), and L-type calcium current (I(Ca)) were investigated using the whole-cell patch clamp technique. In hypertrophic rats, I(K) was decreased by 28.2%, resulting in significant APD(90) (90% repolarization) prolongation (sham: 55 +/- 3.9, hypertrophy: 98 +/- 11 ms, P = 0.01). Isoproterenol (100 nM)-stimulated I(K) was increased by 54.9% +/- 0.10% in sham-operated rats, but not in hypertrophic rats. On the other hand, isoproterenol increased I(Ca) in both sham-operated (77.7% +/- 7.6%) and hypertrophic rats (69.6% +/- 9.7%). Consequently, isoproterenol prolonged further APD in hypertrophic rats (98 +/- 11 vs. 145 +/- 8.6 ms, P < 0.01), but not in sham-operated rats (55 +/- 3.9 vs. 61 +/- 5.6 ms, n.s.). Forskolin (1 microM, an adenylyl cyclase stimulator) did not enhance I(K) in hypertrophic rats, but IBMX (100 microM, a nonselective phosphodiesterase inhibitor) enhanced the current (30.2 +/- 0.05%), as much as in sham-operated rats. We concluded that in hypertrophic hearts, I(K) was not increased by isoproterenol because of the enhanced activity of phosphodiesterase, which leads to excessive APD prolongation.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology

